The conclusions drawn from the analysis provide a basis for more extensive research, especially in human subjects, regarding new treatment possibilities for insulin resistance, particularly in individuals with obesity, in whom adiponectin production is reduced [59]. Here, ADIPOQ is linked to obesity disorder.